This activation of the NRF2/SLC7A11/GPX4 pathway enhanced GSH levels, decreased lipid ROS accumulation, inhibited ferroptosis and lipid peroxidation, and improved the cognitive functions of AD mice (Deng et al., 2025). This evidence concerns the gene GPX4 and Alzheimer disease.